Maintenance notice in CEST time zone (1:00 - 3:30 AM May 17, 2026): Our website is scheduled for maintenance. The website will be available, but some functions may experience errors. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 130209-82-4 | Product Number: L0262
Latanoprost
×
Purity: >98.0%(HPLC)
Synonyms:
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
Shipping Information
|
|---|---|---|---|---|---|
| 10MG |
123,00 €
|
1 | 1 |
|
|
| 50MG |
431,00 €
|
2 | 36 |
|
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
Supplemental Product Information:
Due to the limited filling volume, some of the product may stick to the inner walls of the bottle.
| Product Number | L0262 |
Purity / Analysis Method 
|
>98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__6H__4__0O__5 = 432.60 |
| Physical State (20 deg.C) | Liquid |
| Storage Temperature
|
Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 130209-82-4 |
| Reaxys Registry Number | 5912370 |
| PubChem Substance ID | 253662165 |
| Merck Index (14) | 5376 |
| MDL Number | MFCD00216074 |
Specifications
| Appearance | Colorless to Light yellow clear liquid |
| Purity(HPLC) | min. 98.0 area% |
| Specific rotation [a]20/D | +33.0 to +36.0 deg(C=1, CHCl3) |
Properties (reference)
| Flash point | 188 °C |
| Specific Rotation | 34° (C=1,CHCl3) |
| Solubility in water | Insoluble |
GHS
| Hazard Statements | H413 : May cause long lasting harmful effects to aquatic life. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. |
Related Laws:
| RTECS# | MJ9669550 |
Transport Information:
| HS Number | 2937500000 |
Application
Latanoprost: A Selective Prostanoid FP Receptor Agonist
Latanoprost, a phenyl-substituted prostaglandin F2α (PGF2α) analog, is a selective prostanoid FP receptor agonist. It reduces the intraocular pressure (IOP) in both animal and human subjects mainly by enhancing uveoscleral outflow. (The product is for research purpose only.)
References
- Prostaglandin F2α and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species
- Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections
- Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment (a review)
- A review of the use of Latanoprost for glaucoma since its launch
PubMed Literature
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.